LobbyingRio Biopharmaceuticals lobbying by quarter
Rio Biopharmaceuticals's latest lobbying report covers Q2 2026, at $150K. The four quarters Q3 2025–Q2 2026 total $600K. Its first report covers Q2 2025; the issues it reports most are Pharmacy.
Rio Biopharmaceuticals
- Latest quarter
- $150K
- Q2 2026 · 1 reports
- Last 12 months
- $600K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $100K | 1 |
| Q3 2025 | $150K | 1 |
| Q4 2025 | $150K | 1 |
| Q1 2026 | $150K | 1 |
| Q2 2026 | $150K | 1 |
Policy issues the reports name
- Pharmacy5 reports
A report that names several issues counts once for each.
Who was lobbied
- Health & Human Services, Dept of (HHS)5 reports
- Commerce, Dept of (DOC)2 reports
- Executive Office of the President (EOP)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
- White House Office2 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ballard Partners | $700K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALISON ANWAY | LA to Senator Pat Roberts 2006-2010 | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Ballard Partners | $150K |
| 04/19for Q1 | Ballard Partners | $150K |
| 01/15for Q4 2025 | Ballard Partners | $150K |
| 25/10/17for Q3 2025 | Ballard Partners | $150K |
| 25/07/17for Q2 2025 | Ballard Partners | $100K |
| 25/06/23for Q2 2025 | Ballard Partners | Under $5,000 |